Selected research
Market Outlook & Growth Opportunities
Global Immunomagnetic Microspheres Market Outlook and Growth Opportunities 2026
Market perspective
The global Immunomagnetic Microspheres market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Immunomagnetic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Immunomagnetic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Immunomagnetic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Immunomagnetic Microspheres market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Immunomagnetic Microspheres market include BEAVER, Bio Rad, Bioclone, Geno Technology, GenScript, JSR Life Sciences Corporation, Micromod, Miltenyi Biotec and Omega Bio-Tek, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Immunomagnetic Microspheres market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Immunomagnetic Microspheres and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Immunomagnetic Microspheres sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immunomagnetic Microspheres market size, projected growth trends, production technologies, key applications, and end-use industries.
Immunomagnetic Microspheres Segment by Company
BEAVER
Bio Rad
Bioclone
Geno Technology
GenScript
JSR Life Sciences Corporation
Micromod
Miltenyi Biotec
Omega Bio-Tek
Promega
Qiagen
Rockland
Spherotech
Takara
Merck
Thermo Fisher Scientific
Immunomagnetic Microspheres Segment by Type
Agarose Magnetic Beads
Polymer Magnetic Beads
Silicon Magnetic Beads
Others
Immunomagnetic Microspheres Segment by Application
Sample Preparation
Immunoprecipitation Reaction
Protein and Antibody Purification
Others
Immunomagnetic Microspheres Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Immunomagnetic Microspheres status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Immunomagnetic Microspheres market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Immunomagnetic Microspheres significant trends, drivers, influence factors in global and regions.
6. To analyze Immunomagnetic Microspheres competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunomagnetic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunomagnetic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunomagnetic Microspheres.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Immunomagnetic Microspheres market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immunomagnetic Microspheres industry.
Chapter 3: Detailed analysis of Immunomagnetic Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Immunomagnetic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Immunomagnetic Microspheres in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Agarose Magnetic Beads
- Polymer Magnetic Beads
- Silicon Magnetic Beads
- Others
Applications
- Sample Preparation
- Immunoprecipitation Reaction
- Protein and Antibody Purification
- Others
Companies covered
- BEAVER
- Bio Rad
- Bioclone
- Geno Technology
- GenScript
- JSR Life Sciences Corporation
- Micromod
- Miltenyi Biotec
- Omega Bio-Tek
- Promega
- Qiagen
- Rockland
- Spherotech
- Takara
- Merck
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Immunomagnetic Microspheres Sales Value (2021-2032)
- 1.2.2 Global Immunomagnetic Microspheres Sales Volume (2021-2032)
- 1.2.3 Global Immunomagnetic Microspheres Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Immunomagnetic Microspheres Market Dynamics
- 2.1 Immunomagnetic Microspheres Industry Trends
- 2.2 Immunomagnetic Microspheres Industry Drivers
- 2.3 Immunomagnetic Microspheres Industry Opportunities and Challenges
- 2.4 Immunomagnetic Microspheres Industry Restraints
3 Immunomagnetic Microspheres Market by Company
- 3.1 Global Immunomagnetic Microspheres Company Revenue Ranking in 2025
- 3.2 Global Immunomagnetic Microspheres Revenue by Company (2021-2026)
- 3.3 Global Immunomagnetic Microspheres Sales Volume by Company (2021-2026)
- 3.4 Global Immunomagnetic Microspheres Average Price by Company (2021-2026)
- 3.5 Global Immunomagnetic Microspheres Company Ranking (2024-2026)
- 3.6 Global Immunomagnetic Microspheres Company Manufacturing Base and Headquarters
- 3.7 Global Immunomagnetic Microspheres Company Product Type and Application
- 3.8 Global Immunomagnetic Microspheres Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Immunomagnetic Microspheres Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Immunomagnetic Microspheres Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Immunomagnetic Microspheres Market by Type
- 4.1 Immunomagnetic Microspheres Type Introduction
- 4.1.1 Agarose Magnetic Beads
- 4.1.2 Polymer Magnetic Beads
- 4.1.3 Silicon Magnetic Beads
- 4.1.4 Others
- 4.2 Global Immunomagnetic Microspheres Sales Volume by Type
- 4.2.1 Global Immunomagnetic Microspheres Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Immunomagnetic Microspheres Sales Volume by Type (2021-2032)
- 4.2.3 Global Immunomagnetic Microspheres Sales Volume Share by Type (2021-2032)
- 4.3 Global Immunomagnetic Microspheres Sales Value by Type
- 4.3.1 Global Immunomagnetic Microspheres Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Immunomagnetic Microspheres Sales Value by Type (2021-2032)
- 4.3.3 Global Immunomagnetic Microspheres Sales Value Share by Type (2021-2032)
5 Immunomagnetic Microspheres Market by Application
- 5.1 Immunomagnetic Microspheres Application Introduction
- 5.1.1 Sample Preparation
- 5.1.2 Immunoprecipitation Reaction
- 5.1.3 Protein and Antibody Purification
- 5.1.4 Others
- 5.2 Global Immunomagnetic Microspheres Sales Volume by Application
- 5.2.1 Global Immunomagnetic Microspheres Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Immunomagnetic Microspheres Sales Volume by Application (2021-2032)
- 5.2.3 Global Immunomagnetic Microspheres Sales Volume Share by Application (2021-2032)
- 5.3 Global Immunomagnetic Microspheres Sales Value by Application
- 5.3.1 Global Immunomagnetic Microspheres Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Immunomagnetic Microspheres Sales Value by Application (2021-2032)
- 5.3.3 Global Immunomagnetic Microspheres Sales Value Share by Application (2021-2032)
6 Immunomagnetic Microspheres Regional Sales and Value Analysis
- 6.1 Global Immunomagnetic Microspheres Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Immunomagnetic Microspheres Sales by Region (2021-2032)
- 6.2.1 Global Immunomagnetic Microspheres Sales by Region: 2021-2026
- 6.2.2 Global Immunomagnetic Microspheres Sales by Region (2027-2032)
- 6.3 Global Immunomagnetic Microspheres Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Immunomagnetic Microspheres Sales Value by Region (2021-2032)
- 6.4.1 Global Immunomagnetic Microspheres Sales Value by Region: 2021-2026
- 6.4.2 Global Immunomagnetic Microspheres Sales Value by Region (2027-2032)
- 6.5 Global Immunomagnetic Microspheres Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Immunomagnetic Microspheres Sales Value (2021-2032)
- 6.6.2 North America Immunomagnetic Microspheres Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Immunomagnetic Microspheres Sales Value (2021-2032)
- 6.7.2 Europe Immunomagnetic Microspheres Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Immunomagnetic Microspheres Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Immunomagnetic Microspheres Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Immunomagnetic Microspheres Sales Value (2021-2032)
- 6.9.2 South America Immunomagnetic Microspheres Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Immunomagnetic Microspheres Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Immunomagnetic Microspheres Sales Value Share by Country, 2025 VS 2032
7 Immunomagnetic Microspheres Country-level Sales and Value Analysis
- 7.1 Global Immunomagnetic Microspheres Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Immunomagnetic Microspheres Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Immunomagnetic Microspheres Sales by Country (2021-2032)
- 7.3.1 Global Immunomagnetic Microspheres Sales by Country (2021-2026)
- 7.3.2 Global Immunomagnetic Microspheres Sales by Country (2027-2032)
- 7.4 Global Immunomagnetic Microspheres Sales Value by Country (2021-2032)
- 7.4.1 Global Immunomagnetic Microspheres Sales Value by Country (2021-2026)
- 7.4.2 Global Immunomagnetic Microspheres Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.9.2 France Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.16.2 China Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.19.2 India Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Immunomagnetic Microspheres Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Immunomagnetic Microspheres Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Immunomagnetic Microspheres Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 BEAVER
- 8.1.1 BEAVER Company Information
- 8.1.2 BEAVER Business Overview
- 8.1.3 BEAVER Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.1.4 BEAVER Immunomagnetic Microspheres Product Portfolio
- 8.1.5 BEAVER Recent Developments
- 8.2 Bio Rad
- 8.2.1 Bio Rad Company Information
- 8.2.2 Bio Rad Business Overview
- 8.2.3 Bio Rad Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Bio Rad Immunomagnetic Microspheres Product Portfolio
- 8.2.5 Bio Rad Recent Developments
- 8.3 Bioclone
- 8.3.1 Bioclone Company Information
- 8.3.2 Bioclone Business Overview
- 8.3.3 Bioclone Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Bioclone Immunomagnetic Microspheres Product Portfolio
- 8.3.5 Bioclone Recent Developments
- 8.4 Geno Technology
- 8.4.1 Geno Technology Company Information
- 8.4.2 Geno Technology Business Overview
- 8.4.3 Geno Technology Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Geno Technology Immunomagnetic Microspheres Product Portfolio
- 8.4.5 Geno Technology Recent Developments
- 8.5 GenScript
- 8.5.1 GenScript Company Information
- 8.5.2 GenScript Business Overview
- 8.5.3 GenScript Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.5.4 GenScript Immunomagnetic Microspheres Product Portfolio
- 8.5.5 GenScript Recent Developments
- 8.6 JSR Life Sciences Corporation
- 8.6.1 JSR Life Sciences Corporation Company Information
- 8.6.2 JSR Life Sciences Corporation Business Overview
- 8.6.3 JSR Life Sciences Corporation Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.6.4 JSR Life Sciences Corporation Immunomagnetic Microspheres Product Portfolio
- 8.6.5 JSR Life Sciences Corporation Recent Developments
- 8.7 Micromod
- 8.7.1 Micromod Company Information
- 8.7.2 Micromod Business Overview
- 8.7.3 Micromod Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Micromod Immunomagnetic Microspheres Product Portfolio
- 8.7.5 Micromod Recent Developments
- 8.8 Miltenyi Biotec
- 8.8.1 Miltenyi Biotec Company Information
- 8.8.2 Miltenyi Biotec Business Overview
- 8.8.3 Miltenyi Biotec Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Miltenyi Biotec Immunomagnetic Microspheres Product Portfolio
- 8.8.5 Miltenyi Biotec Recent Developments
- 8.9 Omega Bio-Tek
- 8.9.1 Omega Bio-Tek Company Information
- 8.9.2 Omega Bio-Tek Business Overview
- 8.9.3 Omega Bio-Tek Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Omega Bio-Tek Immunomagnetic Microspheres Product Portfolio
- 8.9.5 Omega Bio-Tek Recent Developments
- 8.10 Promega
- 8.10.1 Promega Company Information
- 8.10.2 Promega Business Overview
- 8.10.3 Promega Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Promega Immunomagnetic Microspheres Product Portfolio
- 8.10.5 Promega Recent Developments
- 8.11 Qiagen
- 8.11.1 Qiagen Company Information
- 8.11.2 Qiagen Business Overview
- 8.11.3 Qiagen Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Qiagen Immunomagnetic Microspheres Product Portfolio
- 8.11.5 Qiagen Recent Developments
- 8.12 Rockland
- 8.12.1 Rockland Company Information
- 8.12.2 Rockland Business Overview
- 8.12.3 Rockland Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Rockland Immunomagnetic Microspheres Product Portfolio
- 8.12.5 Rockland Recent Developments
- 8.13 Spherotech
- 8.13.1 Spherotech Company Information
- 8.13.2 Spherotech Business Overview
- 8.13.3 Spherotech Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Spherotech Immunomagnetic Microspheres Product Portfolio
- 8.13.5 Spherotech Recent Developments
- 8.14 Takara
- 8.14.1 Takara Company Information
- 8.14.2 Takara Business Overview
- 8.14.3 Takara Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Takara Immunomagnetic Microspheres Product Portfolio
- 8.14.5 Takara Recent Developments
- 8.15 Merck
- 8.15.1 Merck Company Information
- 8.15.2 Merck Business Overview
- 8.15.3 Merck Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Merck Immunomagnetic Microspheres Product Portfolio
- 8.15.5 Merck Recent Developments
- 8.16 Thermo Fisher Scientific
- 8.16.1 Thermo Fisher Scientific Company Information
- 8.16.2 Thermo Fisher Scientific Business Overview
- 8.16.3 Thermo Fisher Scientific Immunomagnetic Microspheres Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Thermo Fisher Scientific Immunomagnetic Microspheres Product Portfolio
- 8.16.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Immunomagnetic Microspheres Value Chain Analysis
- 9.1.1 Immunomagnetic Microspheres Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Immunomagnetic Microspheres Sales Mode & Process
- 9.2 Immunomagnetic Microspheres Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Immunomagnetic Microspheres Distributors
- 9.2.3 Immunomagnetic Microspheres Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst